Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61K Buy
1,431
+204
+17% +$9.12K ﹤0.01% 1058
2026
Q1
$59.1K Buy
+1,227
New +$57.2K ﹤0.01% 1023
2025
Q4
Sell
-1,242
Closed -$58.6K 1504
2025
Q3
$58.6K Buy
+1,242
New +$59.9K ﹤0.01% 875
2025
Q2
Sell
-1,261
Closed -$69.9K 1560
2025
Q1
$69.9K Sell
1,261
-49
-4% -$2.65K ﹤0.01% 842
2024
Q4
$63.2K Buy
1,310
+72
+6% +$3.66K ﹤0.01% 826
2024
Q3
$71.3K Sell
1,238
-710
-36% -$38.3K ﹤0.01% 811
2024
Q2
$94.7K Buy
1,948
+1,595
+452% +$76.9K ﹤0.01% 823
2024
Q1
$17.6K Buy
+353
New +$17.2K ﹤0.01% 1081
2022
Q2
Sell
-10,977
Closed -$564K 468
2022
Q1
$564K Sell
10,977
-544
-5% -$28.1K 0.01% 245
2021
Q4
$577K Buy
+11,521
New +$570K 0.01% 205

Other funds holding SNY

Mather Group's SNY Position: Q2 2026 in Review

Mather Group increased its Sanofi (SNY) stake by 17% in Q2 2026, buying an estimated $9.12K and bringing the position to 1,431 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #1058.

Mather Group first reported a position in SNY in Q4 2021 and has held it in 10 quarters since. The position peaked at $577K in Q4 2021. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Mather Group held 1,431 shares of Sanofi worth $61K as of Q2 2026.
  • Mather Group bought 204 Sanofi shares in Q2 2026, an estimated $9.12K.
  • Sanofi made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1058 holding.
  • Mather Group first reported a position in Sanofi in Q4 2021 and has held it in 10 quarters since.
  • Mather Group's Sanofi position peaked at $577K in Q4 2021.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.